Search by ticker code:
Generic filters

Search by ticker code:
Generic filters

Search by ticker code:
Generic filters

Why the Doctor Care Anywhere (ASX:DOC) share price is seeing a healthy rise

The Doctor Care Anywhere Group PLC (ASX: DOC) share price is up more than 4% this morning after revealing a healthy update.

Doctor Care Anywhere’s update

This is a UK-based telehealth company that aims to deliver quality patient and clinical care through its digital platform.

In the first quarter of 2021, it reported underlying revenue of £4.4 million, up 16.5% on the fourth quarter of 2020.

Eligible lives represents the number of people who have an entitlement to use the company’s services. It reported that its eligible lives statistic rose 7% quarter on quarter to 2.4 million. It saw ‘activated lives’ of 0.5 million, up 7% quarter on quarter.

It reported that in the first 2021 quarter, there were 90,500 consultations – up 21.9%. Over 34,000 consultations were delivered in March 2021, up 32.3% compared to the best month in the fourth quarter of 2020.

FY21 revenue is expected to at least double compared to FY20. This will be driven by growth in telehealth lives, activations and consultations together with the ability to grow the parts of the business hurt by the lockdowns.

The balance sheet is in a solid position with £35.1 million as at 31 March 2021.

Management comments

Doctor Care Anywhere CEO Bayju Thakar said:

“The perennial demands on traditional health systems combined with government imposed lockdowns which are now easing in the UK, have fostered a level of adoption and acceptance of telehealth services in the past twelve months, by both patients and clinicians, that might previously have taken five years. 

The speed of the UK vaccine rollout will allow our secondary care services, such as diagnostics, to open and this will further support our growth as hospital availability returns to normal.”

The CEO went onto say that the business has considerable confidence that the business can continue to grow rapidly in both the UK and international markets.

Summary thoughts on the Doctor Care Anywhere share price

The gross profit margin has been temporarily impacted because of increase demand on the doctors and services to deliver on the national vaccine rollout. It expects this reduction to be temporary and that the margin will normalise.

The company pointed out that the global telehealth market is estimated to have been worth US$5.3 billion in 2019 and reach US$14.9 billion by 2024, growing at a compound annual growth rate of 23.1%. That gives the company plenty of organic and acquisition growth opportunities as it seeks to grow internationally.

I think the Doctor Care Anywhere share price is definitely one to watch if it can keep growing. It’s a huge addressable market to grow into.

$50,000 per year in passive income from shares? Yes, please!

With interest rates UP, now could be one of the best times to start earning passive income from a portfolio. Imagine earning 4%, 5% — or more — in dividend passive income from the best shares, LICs, or ETFs… it’s like magic.

So how do the best investors do it?

Chief Investment Officer Owen Rask has just released his brand new passive income report. Owen has outlined 10 of his favourite ETFs and shares to watch, his rules for passive income investing, why he would buy ETFs before LICs and more.

You can INSTANTLY access Owen’s report for FREE by CLICKING HERE NOW and creating a 100% FREE Rask Account.

(Psst. By creating a free Rask account, you’ll also get access to 15+ online courses, 1,000+ podcasts, invites to events, a weekly value investing newsletter and more!)

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.

Information warning: The information on this website is published by The Rask Group Pty Ltd (ABN: 36 622 810 995) is limited to factual information or (at most) general financial advice only. That means, the information and advice does not take into account your objectives, financial situation or needs. It is not specific to you, your needs, goals or objectives. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. Please read our Terms and Conditions and Financial Services Guide before using this website. The Rask Group Pty Ltd is a Corporate Authorised Representative (#1280930) of AFSL #383169.

At the time of publishing, the author of this article does not have a financial or commercial interest in any of the companies mentioned.
Skip to content